AAIC 2025 Abstract
Fostering a comprehensive understanding of neurodegenerative biomarkers through collaborations: Integration of findings from a randomized controlled trial and postmortem datasets
Trial in peopleBiomarkers
Abstract
Background: Neurodegenerative biomarkers, including Amyloid‐β40, 42, Neurofilament light chain (NfL), Glial fibrillary acidic protein (GFAP), and p ‐Tau 217, are considered promising hallmarks of Alzheimer's Disease and Related Dementias (AD/ADRD).
